Cash in on a profitable end to the oil era
Cheap oil stocks could still make a lot of money and carve out a new future before oil demand peaks
Everybody hates oil stocks. Income seekers are scared by the dividend cuts. Sustainable investors don’t like the pollution. Momentum traders aren’t interested in anything that’s not tech. And everybody else looks at the red ink in recent results and steers clear. So it’s understandable that most of the oil majors – BP, Chevron, ConocoPhillips, Eni, Equinor (formerly Statoil), ExxonMobil, Royal Dutch Shell and Total – are down 40%-60% this year.
With yields of 5% or more even after cuts, these firms look cheap if the oil price recovers once Covid-19 passes. Crude is $40 per barrel now, but was $60-$70 last year, at which point the majors are very profitable. The strongest argument against them is that oil is on its way out faster than expected. BP now forecasts that demand will peak around 2030 and could then drop rapidly. The world would still need some oil, but potential supply would far exceed demand. That would mean low prices, so low-cost sources (eg, Saudi Arabia) might drive out other producers.
This is a very plausible scenario. And yet if the majors respond to the implications, they could still be excellent investments.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Dwindling reserves
All these firms have limited reserves, ranging from eight years of production for Shell to 17 for Exxon. If they want to keep producing oil, they must constantly invest in new reserves. And in all the parts of the world that the majors can access, new fields are harder to find and produce than their existing ones. Between 2008 and 2017, the five biggest – BP, Chevron, Exxon, Shell and Total – generated $1.5trn in cash, but reinvested four-fifths of it, according to Bloomberg.
If demand will shrink in a decade, a better strategy may be to stop investing in finding new reserves and run down existing ones to maximise free cash flow (see below) before demand peaks. The cash can be paid out as dividends, invested in new energy – such as offshore wind – or a mix of both.
The European majors appear to be moving in this direction. The US ones – always sceptical about an end to the oil era – are not. It’s possible that both strategies may work out – the last major still pumping oil could earn good returns.
There are risks. Crude might not get back to the $60-$70 range needed to produce lots of cash while running down reserves. Investing in non-oil projects may deliver a poor return. A return to high oil prices could tempt them to resume investing in expensive new fields. But these valuations are pricing in a lot of doubt. Oil majors feel a little like tobacco did in 2000. Out of favour, but with more cash and better prospects than tech-crazed investors think.
I wish I knew what free cash flow was, but I’m too embarrassed to ask
Free cash flow (FCF) measures a firm’s ability to generate spare cash that can be returned to shareholders as dividends or share buybacks, or used to pay down debts. FCF shows how much money is left over after all the costs of doing business and making capital investments.
Free cash flow is important because a business needs to generate excess cash if it’s going to reward investors. If the amount of cash it produces is little more than it needs to survive, it’s not going to be a good long-term investment. In addition, cash flow is harder to fake than accounting profits (net income or earnings per share) so can provide a useful check on whether the company is doing as well as it claims.
How you define FCF depends on whether you are an investor in debt (bonds or loans) or in equity (shares), and whether you want to carry out a more precise calculation or a rough estimate. The most common approach is to take earnings before interest and tax from the income statement, add back depreciation and amortisation (these are non-cash accounting measures that allow for the fact that the value of assets reduce over time), and subtract capital expenditure, changes in working capital and taxes. Alternatively, take cash from operations from the cash flow statement, add back the after-tax cost of interest and subtract capital expenditure.
This gives free cash flow to the firm (FCFF), which is what concerns a debt investor. Equity investors get what’s left over after paying creditors, so they may also look at free cash flow to equity (FCFE), which deducts the after-tax cost of interest and net repayment of debt (be alert for situations where this is being distorted by a big increase in borrowing).
Free cash flow is used in valuation tools such as free cash flow yield (FCF per share ÷ share price), as well as more complex discounted cash flow models. You can also look at profitability metrics such as the free cash flow margin (FCF ÷ sales).
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Cris Sholto Heaton is an investment analyst and writer who has been contributing to MoneyWeek since 2006 and was managing editor of the magazine between 2016 and 2018. He is especially interested in international investing, believing many investors still focus too much on their home markets and that it pays to take advantage of all the opportunities the world offers. He often writes about Asian equities, international income and global asset allocation.
Cris began his career in financial services consultancy at PwC and Lane Clark & Peacock, before an abrupt change of direction into oil, gas and energy at Petroleum Economist and Platts and subsequently into investment research and writing. In addition to his articles for MoneyWeek, he also works with a number of asset managers, consultancies and financial information providers.
He holds the Chartered Financial Analyst designation and the Investment Management Certificate, as well as degrees in finance and mathematics. He has also studied acting, film-making and photography, and strongly suspects that an awareness of what makes a compelling story is just as important for understanding markets as any amount of qualifications.
-
Higher rates are disappearing – should you fix your savings?
Fixed savings rates have dropped to their lowest levels in over a year. Should you fix your savings now ahead of a potential base rate cut in November?
By Katie Williams Published
-
Nine million people fall victim to financial scams, says Citizens Advice
The charity says that around one in five people across the UK have been caught out by a finance scam in the past year - here is how to protect your money
By Chris Newlands Published
-
What will a broken-up Google look like?
The US courts have ruled that Google is a monopoly, leaving it facing the prospect of a break-up. WIll that be a good thing?
By Matthew Lynn Published
-
How will the UK gambling sector be hit by the Budget?
There are concerns for the UK gambling sector in the lead-up to the Autumn Budget. What could be on the cards?
By Dr Matthew Partridge Published
-
HSBC returns to cost-cutting plan
HSBC is set to revamp its commercial banking division – but will it come at a cost?
By Dr Matthew Partridge Published
-
Pfizer shares rise as US investor takes $1 billion stake
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
By Dr Matthew Partridge Published
-
Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
By Dr Matthew Partridge Published
-
How to invest in the quiet market months
Here's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
By Cris Sholto Heaton Published
-
Spire Healthcare: invest in the booming demand for private healthcare
Spire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
By Rupert Hargreaves Published
-
Are insurance companies a good investment?
Costs may be soaring but the insurance sector is currently going through one of its most profitable periods. The market has been slow to realise the opportunity here
By Rupert Hargreaves Published